SCHEMBL2590627

SCHEMBL2590627

NC(CCC[C@H](N)[C]=O)C(=O)CC[C@H](N)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.47
CYP1A2 P05177 2/20 0.47
GRM8 O00222 2/20 0.47
GRM6 O15303 2/20 0.47
GRM7 Q14831 2/20 0.47
GRM4 Q14833 2/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
GRIK1 P39086 1/20 0.47
GRM5 P41594 1/20 0.47
GRIA1 P42261 1/20 0.47
GRIA2 P42262 1/20 0.47
GRIA3 P42263 1/20 0.47
SLC1A3 P43003 1/20 0.47
SLC1A2 P43004 1/20 0.47
SLC1A1 P43005 1/20 0.47
GRIA4 P48058 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIK2 Q13002 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22206267 0.87 GSR (0.60) GSRCYP1A2GRM8GRM6GRM7
SCHEMBL136970 0.87 GSR (0.60) GSRCYP1A2GRM8GRM6GRM7
SCHEMBL2593867 0.86 CHRM2 (0.39) GSRCYP1A2GRM8GRM6GRM7
SCHEMBL3951755 0.80 KMT2A (0.55) GSRCYP1A2GRM8GRM6GRM7
Glutamic Acid SCHEMBL7821241 0.78 GRM8 (0.72) GSRCYP1A2GRM8GRM6GRM7
SCHEMBL542836 0.75 GRM8 (0.82) GSRCYP1A2GRM8GRM6GRM7
SCHEMBL29373318 0.75 GRM8 (0.82) GSRCYP1A2GRM8GRM6GRM7
SCHEMBL27950028 0.75 GRM8 (0.82) GSRCYP1A2GRM8GRM6GRM7
SCHEMBL839697 0.75 GRM8 (0.82) GSRCYP1A2GRM8GRM6GRM7
SCHEMBL542624 0.75 GRM8 (0.82) GSRCYP1A2GRM8GRM6GRM7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227503-A1 POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF UNIVERSITE PAUL SABATIER TOULOUSE III (FR) 2023-07-20 US disclosed
US-20190010191-A1 POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF UNIVERSITE PAUL SABATIER TOULOUSE III (FR) 2019-01-10 US disclosed
US-20170260235-A1 POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF UNIVERSITE PAUL SABATIER (TOULOUSE III) (FR) 2017-09-14 US disclosed
US-9617307-B2 Polypeptide expressed in the stratum corneum and use thereof UNIVERSITE PAUL SABATIER (TOULOUSE III) (FR) 2017-04-11 US disclosed
US-20150299260-A1 POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2015-10-22 US disclosed
US-9085635-B2 Polypeptide expressed in the stratum corneum and thereof CHANEL PARFUMS BEAUTE (FR) 2015-07-21 US disclosed
EP-2563807-A1 POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF Chanel Parfums Beauté (FR) 2013-03-06 EP disclosed
US-20130053327-A1 POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF CHANEL PARFUMS BEAUTE (FR) 2013-02-28 US disclosed
WO-2011135253-A1 POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF CHANEL PARFUMS BEAUTE (FR) 2011-11-03 WO disclosed
US-4916070-A Fibrin-specific antibodies and method of screening for the antibodies THE GENERAL HOSPITAL CORPORATION (US) 1990-04-10 US disclosed
EP-0249007-A2 A method of screening hybridomas THE GENERAL HOSPITAL CORPORATION (US) 1987-12-16 EP disclosed
WO-1987006263-A1 FIBRIN-SPECIFIC ANTIBODIES AND METHOD OF SCREENING FOR THE ANTIBODIES THE GENERAL HOSPITAL CORPORATION (US) 1987-10-22 WO disclosed